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Aim: The aim of this cross-sectional analysis was to identify sociodemographic, and health 
related predictors for fasting use among patients of a large integrative internal medicine ward. 
Methods: A cross-sectional analysis was conducted among patients being referred to a 
hospital for internal and integrative medicine. Patients’ ever-use of fasting for their primary 
medical complaint and their perceptions of benefit and harm were assessed. The potential 
predictors of fasting use included sociodemographic characteristics, health behaviour, internal 
medicine diagnosis, health, satisfaction with health, and health locus of control; and they were 
analysed using multiple logistic regression analysis. 
Results: Of 2144 respondents, 15.8% reported having used fasting, with 61.2% reporting 
perceived benefits and 3.9% harms due to use. Fasting use was positively associated with 
higher education, being diagnosed with osteoarthritis or fibromyalgia and regular fast food 
use, while patients with inflammatory bowel diseases, smokers, alcohol abstinent people and 
those with a high external social health locus of control were less likely to use fasting. A good 
health status and high internal locus of control were positively associated with the perception 
of fasting as helpful, while part-time employment, being diagnosed with inflammatory bowel 
diseases and being alcohol abstinent were negatively associated with perceived helpfulness. 
Conclusion: There is significant use of therapeutic fasting by integrative medicine patients in 













patients was not related to evidence of efficacy of fasting for their condition, with other 
factors being more predictive of fasting use.  
 




Apart from involuntary fasting due to food unavailability and religious or spiritual reasons for 
fasting (such as Muslim Ramadan or Christian Lent), fasting has also been used as a 
therapeutic intervention in a multitude of traditional and ethnomedical systems worldwide [1]. 
When deprived of food, the human body employs various behavioural, biochemical, 
physiological, and structural responses to reduce metabolism, which prolongs the period in 
which energy reserves can cover all metabolic and physiological needs [2]. In therapeutic 
fasting, a nutritional intake below 500 kcal/day is aimed for as this has been shown to induce 
strong neuroendocrine and metabolic responses which are hypothesised to improve health [1, 
3]. Caloric restriction, alternate-day fasting or other types of intermittent fasting appear to be 
associated with prevention of some chronic diseases [1, 4-8]. Therapeutic fasting therapy has 
been shown to alleviate symptom burden in rheumatoid arthritis [9]; reduce the risk of 
coronary artery disease and diabetes mellitus [10-12]; and has been argued to generally 
improve mood disorders [13, 14]. Fasting has also been found beneficial in cancer prevention 
and treatment [5], and experimental research has also produced promising evidence that 
fasting and/or caloric restriction may delay aging and the onset of age-related and 
neurodegenerative diseases [15]. 
Historically, therapeutic fasting was well represented in traditional practice, but its use had 













years. However, recent reports suggest the promotion of fasting as a therapeutic intervention 
has increased and the few studies that have examined such use (from Germany and the United 
States, albeit each from over 10 years ago) indicate that it is gaining in popularity as a self-
care method for prevention and health promotion [16, 17]. However, despite the popularity 
and potential promise of therapeutic fasting as a preventive measure, little is known about the 
prevalence of therapeutic fasting use, factors associated with the use of therapeutic fasting, or 
the characteristics of individuals using therapeutic fasting. In direct response to this research 
gap, the study presented here aims to identify socio-demographic and health related predictors 
of therapeutic fasting use among patients in an integrative internal medicine ward for their 
primary medical complaints.  
 
Material and Methods 
Design 
This survey was part of an internal quality assurance evaluation at the Department for Internal 
and Integrative Medicine, Essen, Germany. The hospital offers an integrative treatment for 
patients diagnosed with chronic diseases of rheumatological, gastrointestinal, pulmonological, 
and cardiovascular origin, including those with chronic pain syndromes; where evidence-
based complementary medical approaches, mind/body medical elements, and physiotherapy 
are integrated into the conventional medical care [18]. Main diagnosis, age and gender were 
obtained from hospital records; all other data were gathered via self-rated paper and pencil 














The survey was conducted in compliance with the Helsinki Declaration. No approval was 
required from an ethics committee according to German law. All included patients provided 
written informed consent, and all data were analysed anonymously. 
Participants 
All patients diagnosed with an internal medicine condition [18] and who were referred to the 
Department for Internal and Integrative Medicine between January 2001 and January 2004 
were invited to complete the survey immediately upon admission. All patients had been 
diagnosed with an internal medicine condition [18].  
Fasting use 
The Freiburg Questionnaire on Attitudes on Naturopathy was used to identify any 
complementary therapies that patients have used for their primary medical complaint before 
they were referred to the clinic [19]. For the analysis reported in this paper, only the question 
on fasting use was evaluated: Have you ever used fasting for your primary medical 
complaint? (Response choice: yes, no). Those patients that reported to have used fasting for 
their primary medical complaint were also questioned about helpfulness: How helpful was 
fasting for your primary medical complaint? (Response choices: helpful, not helpful, 
harmful). Answers were categorised as helpful (yes, no) and harmful (yes, no). No definition 
of fasting was provided; it is commonly understood as a voluntary abstinence from food or 
drink for a period of time. 
Potential predictors of fasting use 
Sociodemographic characteristics 
Linear sociodemographic variables were categorised in order to be able to compute odds 
ratios between fasting users and non-users. Age (18–29, 30–39, 40–49, 50–64, ≥65 years), 













time, unemployed), and family status (in relationship, not in relationship), were used as 
possible predictors together with health behaviours including smoking status (current 
smokers, past smoker, non-smokers), alcohol intake (abstainers, less than twice weekly, at 
least twice weekly), fast food intake (abstainers, less than twice weekly, at least twice 
weekly). 
Clinical characteristics 
The patients’ main diagnosis was assessed by the transferring doctor in accordance to ICD-10 
[20]. For this analysis, diagnoses were categorised as a) osteoarthritis, b) arthritis, c) 
fibromyalgia, d) spinal pain, e) headache, f) other pain, g) hypertension, h) ischemic cardiac 
disease, i) irritable bowel syndrome, j) inflammatory bowel disease, k) lung diseases, l) other, 
more rare conditions. 
General health status was assessed on a 5 point scale and categorised as good, very good or 
excellent versus poor or fair by the patients subjectively. 
Mental health 
Anxiety and depression were assessed using the Hospital Anxiety and Depression Scale 
(HADS) [21]. Scores ranging from 8 to 10 were defined as subthreshold anxiety or depression 
while scores > 10 were defined as threshold anxiety or depression [21].  
Satisfaction with health and life in general (FLZ) 
Satisfaction with health and life in general were assessed using one 5-point Likert item each 
from the questionnaire for life satisfaction (FLZ) [22]. The endpoints were 1=very unsatisfied 
and 5=very satisfied. The higher the score the more satisfied the patient was with health and 
life in general. Every patient was categorised as having either high (i.e. above median) or low 
(i.e. below median) satisfaction with health and satisfaction with life in general.  













Health locus of control was assessed using the GKÜ [23], a 9-item German modified short-
form of the multidimensional health locus of control scale, the most commonly used scale to 
assess health locus of control [24, 25]. Response choices ranged from “strongly disagree” to 
“strongly agree”. The instrument assesses 3 dimensions of health locus of control beliefs (3 
items each): internal (high perceived own influence on health status), external-social (health 
status perceived as controlled by others) and external-fatalistic (health status perceived as 
depending on luck or destiny). For every patient, each dimension was categorised as either 
high (i.e. above median) or low (i.e. below median). 
Statistical analysis 
Chi square tests were used to compare sociodemographic, clinical, and psychological 
characteristics between patients who ever used fasting for their primary medical complaint 
and those who did not. A p-value of ≤0.05 was considered statistically significant. 
Independent predictors of fasting use were identified using multiple logistic regression 
analysis. A backward stepwise procedure with a Wald statistic p-value of ≤0.05 was used. In 
order to be able to compare the individual influence the different variables had on fasting use, 
continuous variables were categorised and adjusted odds ratios with 95% confidence intervals 
were calculated. Among the potential factors that were entered in the initial regression model, 
only factors that were associated with fasting use at a p-value of ≤0.10 in univariate analysis 
were selected. Statistical analysis was performed using IBM SPSS ® software (IBM SPSS 
Statistics for Windows, release 22.0. Armonk, NY: IBM Corp.). 
 
Results 
Of the 2804 patients referred to the department during the 3-year study period, 2486 agreed to 
participate in this survey (88.7% response). Of the respondents, 342 patients (13.8%) did not 













patients. Out of those patients, 1701 (79.3%) were female, mean age was 52.9±14.1 years. 
Most patients were diagnosed with chronic pain; the most commonly diagnosed conditions 
were spinal pain (n=410; 19.1%), headache (n=256; 11.9%), and fibromyalgia (n=246; 
11.5%). Five hundred and seventy seven patients (27.5%) were high school graduates; 565 
(27.4%) were full-time employed; and 339 (16.4%) were part-time employed. 1250 patients 
(59.0%) were in a relationship.  Regarding health behaviour, 1821 (86.8%) regularly 
consumed fast food; 351 (16.6%) regularly consumed alcoholic beverages; and 297 (20.5%) 
currently smoked.  
Three hundred and thirty eight patients (15.8%) reported the use of fasting for their primary 
medical complaint. Of those, 207 (61.2%) reported that fasting had been helpful; and thirteen 
(3.9%) reported that fasting had been harmful.  
Univariate analyses revealed that fasting use was higher in females, those younger than 30 
years or aged 50-64 years, and those with at least high school education, those suffering from 
osteoarthritis, fibromyalgia or other pain, or subthreshold depression, those with high health 
satisfaction, high internal health locus of control and regular fast food consumers. Those 
being aged 30-39 years, those diagnosed with other pain, inflammatory bowel diseases or 
other chronic illnesses, those with high external health locus of control, alcohol abstinent and 
fast food abstinent patients as well as current smokers were less likely to use fasting (Table1). 
In multiple logistic regression analysis, fasting use was positively associated with high school 
level education, suffering from osteoarthritis or fibromyalgia and regular fast food use, while 
patients with inflammatory bowel diseases, smokers, alcohol abstinent people and those with 
a high external social health locus of control were less likely to use fasting, table 2. 
At least good health status and high internal locus of control were positively associated with 













bowel diseases and being alcohol abstinent were negatively associated with perceived 
helpfulness, table 3. 
 
Discussion 
To the author’s knowledge, this is the first comprehensive examination of the prevalence and 
drivers of therapeutic fasting use in a population attending a tertiary care centre. In this 
survey, 15.8% of patients in an integrative internal medicine ward reported having used 
therapeutic fasting for their primary medical complaint. The use of therapeutic fasting was 
positively associated with high school level education, being diagnosed with osteoarthritis or 
fibromyalgia and regular fast food use, while patients with inflammatory bowel diseases, 
smokers, alcohol abstinent people and those with a high external social health locus of control 
were less likely to use therapeutic fasting. 
A good health status and high internal locus of control were positively associated with the 
perception of therapeutic fasting as helpful, while part-time employment, being diagnosed 
with inflammatory bowel diseases and being alcohol abstinent were all negatively associated 
with the perception of therapeutic fasting as unhelpful. 
Several findings are worthy of further discussion. The first is the relationship (or rather lack 
thereof) of evidence of therapeutic fasting efficacy with patient use of fasting to treat their 
primary medical conditions. Patients with fibromyalgia and osteoarthritis for example have 
been found to be more likely to use therapeutic fasting, even though there is limited evidence 
of efficacy of fasting in those complaints [26], suggesting factors beyond the clinical evidence 
base are influencing patient decision-making to use fasting, including attitudes to general 













It is also known that patients with fibromyalgia are frequent consumers of complementary 
medicines, and almost every third German fibromyalgia patient has used some kind of dietary 
regime that is often associated with complementary medicine approach (which may include 
fasting, an ‘elimination’ diet or vegetarian diet) [27]. Therefore one of the confounding 
variables of therapeutic fasting use may be use of complementary approaches to healing, 
which may include therapeutic fasting as a component. Further research should examine the 
influence of complementary medicine philosophies on practice of fasting, as this may impact 
the accessibility and acceptability of therapeutic fasting in various patient groups and settings.  
High use of fasting was also uncovered in patients with osteoarthritis, even though the 
evidence base for the efficacy of therapeutic fasting for osteoarthritis is also relatively 
underdeveloped [28]. One factor that might link osteoarthritis and fibromyalgia to fasting may 
be overweight and obesity which are more prevalent in those patients compared to healthy 
people. For both, overweight and obesity have been identified as risk factors [29-31], and 
those conditions might contribute to the progression of the disease [31, 32].  
Given this association between overweight and fibromyalgia/osteoarthritis, the use of fasting 
by our participants may not have been to address pain, but also in response to losing weight, 
which is one of the most popularly promoted therapeutic aims of fasting [33, 34]. A possible 
link to use of fasting for weight loss might be supported by another finding of the study, 
which showed that patients with regular fast food consumption were more likely to use 
fasting, indicating its possible use as a compensatory measure for their particular eating 
habits. However, it is likely that therapeutic fasting is a compensatory measure for dietary 
habits alone, as other unhealthful behaviours (such as smoking and alcohol consumption) 
were negatively associated with therapeutic fasting use.    
The lack of relationship between evidence of efficacy in conditions and patient use of fasting 













to our analysis, patients with rheumatoid arthritis were not more likely to use fasting than 
patients with other conditions. Therapeutic fasting is indicated for rheumatologic conditions 
though this generally only applies to inflammatory rheumatic diseases like rheumatoid 
arthritis for which several studies have found beneficial effects [1, 9, 35, 36].  
Thirteen participants (3.9%) in our study claimed that fasting had been harmful to their health, 
however, no detailed data on those cases were available. This figure is slightly higher than an 
earlier study [37] on inpatients in an integrative medicine ward, which found that 2.3% of 
patients stopped therapeutic fasting therapy prematurely, mainly because of hunger or 
irritability. Side effects in that study included two cases of hypernatremia, and one case of 
increase in uric acid in a patient with gout, but all those resolved quickly with medical 
treatment. These results also concord with a systematic review of therapeutic fasting, which 
demonstrated that the therapy was relatively safe but did carry a small but risk of significant 
harm [33] - and highlights the necessity to use fasting only after careful consideration and 
under supervision or monitoring in patients with medical history [38]. Our study confirms the 
need for judicious monitoring, though also highlights the relatively safe nature of therapeutic 
fasting. 
Whereas evidence for efficacy did not seem to correlate with patient use of therapeutic 
fasting, patients seemed more likely to follow the evidence base when it came to 
contraindications of therapeutic fasting use. For example, participants with inflammatory 
bowel diseases were significantly less likely to use fasting. As these participants are at risk of 
malnutrition and nutritional deficiencies [39, 40] which is associated with an increase of the 
disease specific mortality risk [41] therapeutic fasting is usually contraindicated in those 
patients. It should be noted, however, that while there is little empirical evidence for fasting in 
these conditions, traditional use and anecdotal patient reports indicate this as one of the more 













of fasting appears not only to be unrelated to what has been shown to be effective in the 
literature, but also appears discordant from traditional indications, highlights the need for 
research on the efficacy and safety of fasting for patients’ health and well-being to be 
adequately informed by prevalence of use data.  
The disconnect between the scientific and traditional evidence base and use of therapeutic 
fasting in the study’s participants can be suggestive that participants – and perhaps the 
clinicians informing them – are not adequately informed about the evidence base for 
therapeutic fasting when implementing it into their treatment plans. However, it may also 
reflect a broader disconnect between those formulating research questions around therapeutic 
fasting and those actually using it for treatment. In most cases the evidence base is degraded 
not by evidence of inefficacy, but by a paucity of evidence more generally. Given the high 
acceptance and use of therapeutic fasting in a wide variety of conditions in which it has not 
been rigorously evaluated, it is imperative that patterns of patient use should be a factor 
considered in the formulation of research questions around evaluation of therapeutic fasting.  
The generalizability of this study’s results might be limited by the single-centre setting and 
the department’s profile; they might therefore only apply to German internal medicine 
patients. While the Department for Internal and Integrative Medicine might specifically attract 
patients who are interested in an integrative medical approach, many patients are referred to 
the department by their general practitioners, and thus patients may not necessarily have been 
experiencing complementary medicine prior to their admission to the hospital. Costs are 
further covered by the German statutory and many private health insurances, providing access 
to integrative care independent of socioeconomic profile. While our study assessed subjective 
perceptions of the effectiveness and safety of fasting, specific fasting methods and frequency 
of fasting, and perceived benefits or risks were not investigated in more detail. In order to 













patients, it is crucial to understand what fasting regimen patients used. The knowledge of the 
specific type of fasting together with frequency and duration however is necessary to gain a 
deeper understanding of why certain individuals may have perceived benefits while other 
have not, and how the specifics of fasting are related to any reported harms. Lastly response 
and recall bias might further limit the validity of results. Despite these limitations, the current 
study may extend previous findings on fasting use in other populations. 
 
Conclusion 
This study found that there is significant use of therapeutic fasting by patients attending an 
integrative internal medicine ward, with high levels of perceived benefit and low incidence of 
self-reported harms. Use of therapeutic fasting by patients does not appear to be related to 
known evidence of efficacy of fasting for their condition – or even traditional use indications 
– with other health utilisation, behavioural, demographic and socio-cultural factors being 
more predictive of fasting use. Findings of this study suggest that more detailed research 
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Table 1: Sociodemographic, clinical, and psychological characteristics of patients who used fasting for 
their primary medical complaint (fasting use) and those who did not (fasting non-use). 
 







Age group    
Less than 30 1.8  6.6 <0.001 
30 to 39 10.1  14.3 0.038 
40 to 49 21.3  19.4 0.413 
50 to 64 46.2  37.9 0.005 
65 or greater 20.7  21.9 0.667 
Gender    
Female  83.4  78.6 0.048 
Education    
High school graduate  34.2  26.2 0.003 
Employment    
Full-time  27.6  27.3 0.946 
Part-time  16.9  16.3 0.807 
In relationship  58.8  59.0 0.952 
Main diagnosis    
Osteoarthritis  11.8  8.6 0.065 
Arthritis  7.4  6.4 0.475 
Fibromyalgia  18.0  10.2 <0.001 
Spinal pain  17.2  19.5 0.366 
Headache  12.7  11.8 0.648 
Other pain  8.0  11.2 0.084 
Hypertension  4.4  3.1 0.244 













Irritable bowel syndrome  3.6  3.1 0.614 
Inflammatory bowel disease 1.5  5.6 0.001 
Lung diseases  4.4  5.2 0.685 
Others  9.8  14.1 0.036 
Health status    
Good, very good or excellent  16.2  16.9 0.811 
Mental health    
Subthreshold anxiety   27.2  25.4 0.494 
Threshold anxiety  32.9  35.8 0.317 
Subthreshold depression  28.1  23.4 0.070 
Threshold depression  20.1  22.3 0.388 
Satisfaction    
High health satisfaction  77.4  70.4 0.008 
High life satisfaction  84.2  83.7 0.872 
Health locus of control    
High internal  65.5  56.8 0.004 
High external-social  60.5  68.8 0.003 
High external-fatalistic  56.1  64.1 0.006 
Health behaviour    
Alcohol    
Abstinent  33.3  42.4 0.002 
Regular use 
Fast food 
 15.0  16.9 0.423 
Abstinent  2.1  4.7 0.037 
Regular use   90.9  86.1 0.017 
Smoking status    
Current smoker  12.3  21.9 0.001 




























Table 2: Independent predictors of fasting for the patient’s primary medical complaints: Results from 
multivariate logistic regression analysis. 
 
Predictor variables p-values Adjusted 
odds ratios 
95% CI 
    
High school graduate 0.007 1.60 1.14-2.26 
Osteoarthritis 0.032 1.70 1.05-2.77 
Fibromyalgia 0.002 1.98 1.28-3.05 
Inflammatory bowel disease 0.016 0.09 0.01-0.64 
High external-social health locus of control 0.005 0.63 0.46-0.87 
Current smoker 0.004 0.52 0.33-0.81 
Alcohol, abstinent 0.046 0.72 0.52-0.99 















Table 3: Independent predictors for perceived helpfulness of fasting for the patient’s primary medical 
complaints: Results from multivariate logistic regression analysis.  
 
Predictor variables p-values Adjusted 
odds ratios 
95% CI 
    
Part-time employment 0.009 0.34 0.15-0.77 
Inflammatory bowel disease 0.012 0.003 0.002-0.48 
Good, very good or excellent health status 0.033 4.02 1.12-14.48 
High internal health locus of control 0.037 2.03 1.04-3.95 
Alcohol, abstinent 0.004 0.38 0.20-0.73 
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